Atlas Trials

Efficacy and Safety of Different Doses of Rivaroxaban in Elderly Chinese Patients With Nonvalvular Atrial Fibrillation

Clinical trial NCT05638100 · UNKNOWN

Trial details

NCT number
NCT05638100
Sponsor
The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School
Status
UNKNOWN
Study type
OBSERVATIONAL
Atrial Fibrillation
Start date
2023-01-01
Primary completion
2025-12-31
Enrollment
300

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.